Crossmark

Antitumor Efficacy of Human Monocyte-Derived Dendritic Cells: Comparing Effects of two Monocyte Isolation Methods

Crossref DOI link: https://doi.org/10.1186/s12575-018-0069-6

Published Online: 2018-02-02

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Marques, Graça S

Silva, Zélia

Videira, Paula A.
Funding

Funding for this research was provided by:

Fundação para a Ciência e a Tecnologia (SFRH/BPD/108686/2015)

Operational Programme for Competitiveness Factors under the Incentives for Research and Technological Development System (38870)
More Information

Article History

Received: 16 November 2017

Accepted: 17 January 2018

First Online: 2 February 2018

Ethics Approval and Consent to Participate

: This article does not contain any studies with human participants. The approval to use peripheral blood mononuclear cells (PBMCs), from leuko-platelet concentrates from healthy anonymous donors, was obtained from the Portuguese Blood and Transplantation Institute (Instituto Português do Sangue e da Transplantação - IPST) (P-0114/CD/12HT/pt); after the approval from the institutional ethical committee. Permission to use the blood cell donations is obtained after informed consent from anonymous donors.

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.